Complement activation products in the urine from proteinuric patients

Yoshiki Morita, Hiroshi Ikeguchi, Jiro Nakamura, Nigishi Hotta, Yukio Yuzawa, Seiichi Matsuo

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

The presence of plasma proteins in the tubular lumen has variety of adverse effects on the tubular cells. Among various plasma proteins filtered through glomerular barrier, complement has been proven as the possible candidate inducing tubulointerstitial injury. To study the role of intratubular complement activation in proteinuric patients, complement activation products (CAP) at C3 level (iC3b and Bb) and C9 level (membrane attack complex) were measured in both plasma and urine of patients with minimal change nephrotic syndrome (MCNS), focal glomerular sclerosis, IgA nephropathy, membranous nephropathy, and diabetic nephropathy. For evaluation of the effect of metabolic acidosis on the intratubular complement activation, urinary CAP were measured before and after sodium bicarbonate administration in patients with renal insufficiency. The following results were obtained: (1) Patients with focal glomerular sclerosis and diabetic nephropathy showed the highest level of urinary CAP excretion rate (unit/creatinine), while MCNS revealed no increase. (2) Patients with membranous nephropathy showed a unique finding, i.e., isolated increase of membrane attack complex excretion. (3) There was no significant correlation between urine and plasma levels of CAP. (4) Except for MCNS patients, the urinary excretion rate of CAP significantly increased when the level of proteinuria exceeded the nephrotic range, and it was significantly correlated with the serum creatinine level. (5) Urinary CAP excretion rate significantly decreased 2 wk after sodium bicarbonate administration without affecting the level of proteinuria or plasma CAP. These results suggest that the degree of intratubular complement activation correlates with the level of proteinuria, type of glomerular disease, impairment of renal function, and metabolic acidosis.

Original languageEnglish
Pages (from-to)700-707
Number of pages8
JournalJournal of the American Society of Nephrology
Volume11
Issue number4
Publication statusPublished - 01-04-2000
Externally publishedYes

Fingerprint

Complement Activation
Urine
Lipoid Nephrosis
Proteinuria
Complement Membrane Attack Complex
Membranous Glomerulonephritis
Sodium Bicarbonate
Diabetic Nephropathies
Sclerosis
Acidosis
Blood Proteins
Creatinine
Complement C3b
Immunoglobulin A
Renal Insufficiency
Kidney

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Morita, Y., Ikeguchi, H., Nakamura, J., Hotta, N., Yuzawa, Y., & Matsuo, S. (2000). Complement activation products in the urine from proteinuric patients. Journal of the American Society of Nephrology, 11(4), 700-707.
Morita, Yoshiki ; Ikeguchi, Hiroshi ; Nakamura, Jiro ; Hotta, Nigishi ; Yuzawa, Yukio ; Matsuo, Seiichi. / Complement activation products in the urine from proteinuric patients. In: Journal of the American Society of Nephrology. 2000 ; Vol. 11, No. 4. pp. 700-707.
@article{80c43f609b9f417a9649b3e4d8873bfe,
title = "Complement activation products in the urine from proteinuric patients",
abstract = "The presence of plasma proteins in the tubular lumen has variety of adverse effects on the tubular cells. Among various plasma proteins filtered through glomerular barrier, complement has been proven as the possible candidate inducing tubulointerstitial injury. To study the role of intratubular complement activation in proteinuric patients, complement activation products (CAP) at C3 level (iC3b and Bb) and C9 level (membrane attack complex) were measured in both plasma and urine of patients with minimal change nephrotic syndrome (MCNS), focal glomerular sclerosis, IgA nephropathy, membranous nephropathy, and diabetic nephropathy. For evaluation of the effect of metabolic acidosis on the intratubular complement activation, urinary CAP were measured before and after sodium bicarbonate administration in patients with renal insufficiency. The following results were obtained: (1) Patients with focal glomerular sclerosis and diabetic nephropathy showed the highest level of urinary CAP excretion rate (unit/creatinine), while MCNS revealed no increase. (2) Patients with membranous nephropathy showed a unique finding, i.e., isolated increase of membrane attack complex excretion. (3) There was no significant correlation between urine and plasma levels of CAP. (4) Except for MCNS patients, the urinary excretion rate of CAP significantly increased when the level of proteinuria exceeded the nephrotic range, and it was significantly correlated with the serum creatinine level. (5) Urinary CAP excretion rate significantly decreased 2 wk after sodium bicarbonate administration without affecting the level of proteinuria or plasma CAP. These results suggest that the degree of intratubular complement activation correlates with the level of proteinuria, type of glomerular disease, impairment of renal function, and metabolic acidosis.",
author = "Yoshiki Morita and Hiroshi Ikeguchi and Jiro Nakamura and Nigishi Hotta and Yukio Yuzawa and Seiichi Matsuo",
year = "2000",
month = "4",
day = "1",
language = "English",
volume = "11",
pages = "700--707",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

Morita, Y, Ikeguchi, H, Nakamura, J, Hotta, N, Yuzawa, Y & Matsuo, S 2000, 'Complement activation products in the urine from proteinuric patients', Journal of the American Society of Nephrology, vol. 11, no. 4, pp. 700-707.

Complement activation products in the urine from proteinuric patients. / Morita, Yoshiki; Ikeguchi, Hiroshi; Nakamura, Jiro; Hotta, Nigishi; Yuzawa, Yukio; Matsuo, Seiichi.

In: Journal of the American Society of Nephrology, Vol. 11, No. 4, 01.04.2000, p. 700-707.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Complement activation products in the urine from proteinuric patients

AU - Morita, Yoshiki

AU - Ikeguchi, Hiroshi

AU - Nakamura, Jiro

AU - Hotta, Nigishi

AU - Yuzawa, Yukio

AU - Matsuo, Seiichi

PY - 2000/4/1

Y1 - 2000/4/1

N2 - The presence of plasma proteins in the tubular lumen has variety of adverse effects on the tubular cells. Among various plasma proteins filtered through glomerular barrier, complement has been proven as the possible candidate inducing tubulointerstitial injury. To study the role of intratubular complement activation in proteinuric patients, complement activation products (CAP) at C3 level (iC3b and Bb) and C9 level (membrane attack complex) were measured in both plasma and urine of patients with minimal change nephrotic syndrome (MCNS), focal glomerular sclerosis, IgA nephropathy, membranous nephropathy, and diabetic nephropathy. For evaluation of the effect of metabolic acidosis on the intratubular complement activation, urinary CAP were measured before and after sodium bicarbonate administration in patients with renal insufficiency. The following results were obtained: (1) Patients with focal glomerular sclerosis and diabetic nephropathy showed the highest level of urinary CAP excretion rate (unit/creatinine), while MCNS revealed no increase. (2) Patients with membranous nephropathy showed a unique finding, i.e., isolated increase of membrane attack complex excretion. (3) There was no significant correlation between urine and plasma levels of CAP. (4) Except for MCNS patients, the urinary excretion rate of CAP significantly increased when the level of proteinuria exceeded the nephrotic range, and it was significantly correlated with the serum creatinine level. (5) Urinary CAP excretion rate significantly decreased 2 wk after sodium bicarbonate administration without affecting the level of proteinuria or plasma CAP. These results suggest that the degree of intratubular complement activation correlates with the level of proteinuria, type of glomerular disease, impairment of renal function, and metabolic acidosis.

AB - The presence of plasma proteins in the tubular lumen has variety of adverse effects on the tubular cells. Among various plasma proteins filtered through glomerular barrier, complement has been proven as the possible candidate inducing tubulointerstitial injury. To study the role of intratubular complement activation in proteinuric patients, complement activation products (CAP) at C3 level (iC3b and Bb) and C9 level (membrane attack complex) were measured in both plasma and urine of patients with minimal change nephrotic syndrome (MCNS), focal glomerular sclerosis, IgA nephropathy, membranous nephropathy, and diabetic nephropathy. For evaluation of the effect of metabolic acidosis on the intratubular complement activation, urinary CAP were measured before and after sodium bicarbonate administration in patients with renal insufficiency. The following results were obtained: (1) Patients with focal glomerular sclerosis and diabetic nephropathy showed the highest level of urinary CAP excretion rate (unit/creatinine), while MCNS revealed no increase. (2) Patients with membranous nephropathy showed a unique finding, i.e., isolated increase of membrane attack complex excretion. (3) There was no significant correlation between urine and plasma levels of CAP. (4) Except for MCNS patients, the urinary excretion rate of CAP significantly increased when the level of proteinuria exceeded the nephrotic range, and it was significantly correlated with the serum creatinine level. (5) Urinary CAP excretion rate significantly decreased 2 wk after sodium bicarbonate administration without affecting the level of proteinuria or plasma CAP. These results suggest that the degree of intratubular complement activation correlates with the level of proteinuria, type of glomerular disease, impairment of renal function, and metabolic acidosis.

UR - http://www.scopus.com/inward/record.url?scp=0034068043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034068043&partnerID=8YFLogxK

M3 - Article

C2 - 10752529

AN - SCOPUS:0034068043

VL - 11

SP - 700

EP - 707

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 4

ER -